Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: AIDS Care. 2020 Jul 2;33(9):1133–1138. doi: 10.1080/09540121.2020.1785999

Table 3:

Number and Proportion of HIV Patients Who Disclosed Their HIV Status to a Spouse or Other Partner, Among Those Newly Enrolling in Care at HIV Clinics in Southern Ethiopia, 2015 to 2017: Relative Risk by Selected Characteristics or Responses (N=966)

Did Not Disclose Disclosed Relative Risk
(N=252) (N=714) (95% CI)
Gender
 Male (N=485) 133 (27%) 352 (73%) Referent
 Female (N=481) 119 (25%) 362 (75%) 1.04 (0.96 – 1.12)
Age (years):
 ≤ 25 (N=181) 52 (29%) 129 (71%) Referent
 26-44 (N=635) 159 (25%) 476 (75%) 1.05 (0.95 – 1.17)
 ≥45 (N=130) 39 (30%) 91 (70%) 0.98 (0.85 – 1.14)
Marital status:
 Single (N=37) 14 (38%) 23 (62%) Referent
 Married (N=846) 178 (21%) 668 (79%) 1.27 (0.99 – 1.64)
 Widow, divorced, separated (N=82) 60 (73%) 22 (27%) 0.43 (0.28 – 0.67)
Education:
 No School (N=239) 69 (29%) 170 (71%) Referent
 Some Primary School (N=462) 115 (25%) 347 (75%) 1.06 (0.96 – 1.16)
 Above Primary School (N=265) 68 (26%) 197 (74%) 1.05 (0.94 – 1.16)
Total social support score on MOS-SSS EI and TA domains combined
 Lowest quartile (12-20) (N=214) 86 (40%) 128 (60%) Referent
 Middle two quartiles (21–47) (N=463) 104 (22%) 359 (78%) 1.30 (1.15 – 1.46)
 Highest (48-60) (N=287) 62 (22%) 225 (78%) 1.31 (1.16 – 1.49)
Total score on MOS-SSS EI support domain
 Lowest (8-11) (N=235) 82 (38%) 133 (62%) Referent
 Middle (12-31) (N=436) 110 (24%) 348 (76%) 1.23 (1.09 – 1.38)
 Highest (32-40) (N=304) 60 (21%) 232 (79%) 1.28 (1.14 – 1.45)
Total score on MOS-SSS TA support domain
 Lowest (4-7) (N=166) 71 (43%) 95 (57%) Referent
 Middle (8-16) (N=549) 124 (23%) 425 (77%) 1.35 (1.18 – 1.55)
 Highest (17-20) (N=250) 57 (23%) 193 (77%) 1.35 (1.16 – 1.56)
Chronic disease symptoms
 1-6 symptoms (N=787) 211 (27%) 576 (73%) Referent
 None (N=179) 41 (23%) 138 (77%) 1.05 (0.96 – 1.15)
WHO clinical stage
 Stage I or II (N=582) 142 (24%) 440 (76%) Referent
 Stage III or IV (N=376) 108 (29%) 268 (71%) 0.94 (0.87 – 1.02)
CD4+ (cells/mm3)
 ≥200 (N=483) 128 (27%) 355 (73%) Referent
 <200 (N=304) 75 (25%) 229 (75%) 1.02 (0.94 – 1.11)
Able to carry out normal activities of daily living
 Unable to carry out (N=133) 33 (25%) 100 (75%) Referent
 Able to carry out (N=831) 218 (26%) 613 (74%) 0.98 (0.88-1.09)
Responses to HIV knowledge questions
 <6 correct responses (N=362) 97 (27%) 264 (73%) Referent
 6-8 correct responses (N=604) 155 (26%) 449 (74%) 1.02 (0.94- 1.10)
Significant depression (CES-D-10 score >10)
 Yes (N=465) 128 (28%) 337 (72%) Referent
 No (N=501) 124 (25%) 377 (75%) 1.04 (0.96–1.12)
Length of time since first learned HIV status
 0–2 months (N=609) 182 (30%) 427 (70%) Referent
 3–12 months (N=168) 43 (26%) 125 (74%) 1.06 (0.96 – 1.18)
 >12 months (N=167) 21 (13%) 146 (87%) 1.25 (1.15 – 1.35)

Abbreviations: RR=Relative Risk, CI= Confidence intervals, MOS-SSS= Medical Outcome Study Social Support Survey, EI=emotional/informational support, TA=Tangible assistance support, CESD-10= Centre for Epidemiologic Studies Depression Scale (10 item)